RecruitingPhase 1 / Phase 2NCT06546670
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Sponsor: Novartis Pharmaceuticals
New York, NY · +8 more sites
Sickle Cell Disease clinical trials in New York, NY
14 recruiting sickle cell disease studies with a site in New York, NY.
RecruitingNot applicableNCT06374238
Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
Sponsor: University of Pittsburgh
New York, NY · Rochester, NY · +12 more sites
RecruitingPhase 2NCT06699849
Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
Sponsor: CSL Behring
New York, NY · The Bronx, NY · +18 more sites
RecruitingPhase 1NCT07187973
A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
Sponsor: Disc Medicine, Inc
New York, NY · +10 more sites
RecruitingPhase 3NCT06609226
A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
Sponsor: Novo Nordisk A/S
Brooklyn, NY · New York, NY · +36 more sites
RecruitingPhase 2 / Phase 3NCT05431088
A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
Sponsor: Pfizer
New York, NY · The Bronx, NY · +44 more sites
RecruitingPhase not listedNCT04398628
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Sponsor: American Thrombosis and Hemostasis Network
Buffalo, NY · Hyde Park, NY · New York, NY · +73 more sites
RecruitingPhase 1 / Phase 2NCT04819841
Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease
Sponsor: Kamau Therapeutics
New York, NY · +4 more sites
RecruitingPhase 1NCT07015684
131I-apamistamab-based Conditioning for Hematopoietic Stem Cell Transplant (HSCT) in Advanced Sickle Cell Disease (SCD)
Sponsor: Columbia University
New York, NY
RecruitingPhase not listedNCT06941389
Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
Sponsor: University of Rochester
Buffalo, NY · New York, NY · Queens, NY · +28 more sites
RecruitingPhase 3NCT05477563
Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease
Sponsor: Vertex Pharmaceuticals Incorporated
New York, NY · +2 more sites
RecruitingPhase 2NCT03587272
Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease
Sponsor: Robert Nickel
New York, NY · +4 more sites
RecruitingPhase not listedNCT07373639
A Long-term Follow-up Study in Patients Who Received BEAM-101
Sponsor: Beam Therapeutics Inc.
New York, NY · +16 more sites
RecruitingPhase 2NCT05519111
Cannabinoids for the Reduction of Inflammation and Sickle Cell Related Pain
Sponsor: Icahn School of Medicine at Mount Sinai
New York, NY
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.